USE OF DOPAMINE AUTORECEPTOR AGONISTS IN THE TREATMENT OF DRUG DEPENDENCY

The invention relates to the use of dopamine autoreceptor agonists, in particular of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine (BHT 920) and (S)-2-amino-4,5,6,7-tetrahydro-6-n-propylaminobenzothiazole (SND 919), for producing medicaments for the treatment of drug dependency.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SCHINGNITZ, GUENTER, KUTTER, EBERHARD, DR
Format:	Patent
Sprache:	eng ; ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to the use of dopamine autoreceptor agonists, in particular of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine (BHT 920) and (S)-2-amino-4,5,6,7-tetrahydro-6-n-propylaminobenzothiazole (SND 919), for producing medicaments for the treatment of drug dependency.